Resoconti Y-mAbs Therapeutics, Inc.

Azioni

YMAB

US9842411095

Mercato chiuso - Nasdaq Altri mercati azionari 19:00:00 03/07/2024			Variaz. 5gg	Var. 1 gen.
11,38 ^USD	+0,09%		-5,40%	+66,86%

05/06	Y-mAbs Therapeutics, Inc. nomina Norman LaFrance come responsabile dello sviluppo	CI
01/06	Y-mAbs Therapeutics, Inc. annuncia la pubblicazione dei dati preclinici di GD2-SADA	CI

Resoconti

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024	08/05
Transcript : Y-mAbs Therapeutics, Inc., Q4 2023 Earnings Call, Mar 01, 2024	01/03
Transcript : Y-mAbs Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 05:15 PM	11/01
Transcript : Y-mAbs Therapeutics, Inc., Q3 2023 Earnings Call, Nov 14, 2023	14/11
Transcript : Y-mAbs Therapeutics, Inc., Q2 2023 Earnings Call, Aug 11, 2023	11/08/23
Transcript : Y-mAbs Therapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023	09/05/23
Transcript : Y-mAbs Therapeutics, Inc., 2022 Earnings Call, Mar 31, 2023	31/03/23
Transcript : Y-mAbs Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 02:15 PM	11/01/23
Transcript : Y-mAbs Therapeutics, Inc. - Special Call	14/12/22
Transcript : Y-mAbs Therapeutics, Inc., Q3 2022 Earnings Call, Nov 08, 2022	08/11/22
Transcript : Y-mAbs Therapeutics, Inc., Q2 2022 Earnings Call, Aug 09, 2022	09/08/22
Y-mAbs Therapeutics, Inc. Ribadisce le previsioni di fatturato per l'intero anno 2022	08/08/22	CI
Transcript : Y-mAbs Therapeutics, Inc., Q1 2022 Earnings Call, May 10, 2022	10/05/22
Y-mAbs Therapeutics, Inc. Fornisce la previsione delle entrate per l'intero anno 2022	27/04/22	CI
Transcript : Y-mAbs Therapeutics, Inc., 2021 Earnings Call, Feb 25, 2022	25/02/22
Transcript : Y-mAbs Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 09:00 AM	11/01/22
Transcript : Y-mAbs Therapeutics, Inc. - Special Call	15/12/21
Transcript : Y-mAbs Therapeutics, Inc., Q3 2021 Earnings Call, Nov 05, 2021	05/11/21
Transcript : Y-mAbs Therapeutics, Inc. - Special Call	23/09/21
Transcript : Y-mAbs Therapeutics, Inc., Q2 2021 Earnings Call, Aug 06, 2021	06/08/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Resoconti Y-mAbs Therapeutics, Inc.

Azioni

YMAB

US9842411095

Resoconti

Filtri